Semax Peptide – Premium Research-Grade Nootropic Peptide (ACTH 4-7 Analog)

Semax Peptide is a high-purity synthetic heptapeptide supplied exclusively for laboratory and scientific research applications. Developed as a stabilized analog of the adrenocorticotropic hormone fragment ACTH(4-7), Semax has become one of the most extensively studied nootropic peptides in modern neuroscience research. Every batch is produced to strict quality standards, giving researchers a consistent, reliable compound for exploring neurotransmitter modulation, neuroprotection, and cognitive pathways.

What is Semax Peptide?

Semax is a laboratory-synthesized polypeptide derived from the 4-7 fragment of adrenocorticotropic hormone (ACTH), a hormone normally secreted by the anterior pituitary gland. Notably, research indicates that this fragment does not reproduce the hormonal activity of ACTH itself; instead, it appears to act selectively within the brain. To overcome the natural instability of endogenous peptides — which are readily broken down by enzymes in gastrointestinal and cerebrospinal fluids — scientists extended the core Met-Glu-His-Phe sequence with a Pro-Gly-Pro (PGP) tail at the C-terminus. This structural modification is thought to increase lipophilicity, potentially improving the molecule's ability to cross the blood-brain barrier, while N-terminal acetylation may further protect it from enzymatic degradation and extend its functional half-life in biological systems.

Key Research Benefits & Effects

• Nootropic Potential: Animal studies report that Semax exposure elevated the serotonin metabolite 5-HIAA by up to 180% within four hours, suggesting enhanced serotonergic activity linked to mood, cognition, and central nervous system function.
• Neurotransmitter Modulation: Research suggests Semax may inhibit select enkephalin-degrading enzymes, indirectly influencing dopamine and serotonin systems involved in pain perception and stress response.
• Neurotrophic Support: Studies indicate Semax may stimulate dopamine release and increase brain-derived neurotrophic factor (BDNF), a key protein associated with neuronal growth and plasticity.
• Anxiolytic Activity in Models: In neonatal rodent studies, Semax appeared to reverse anxiety-like behaviors induced by early SSRI exposure or maternal deprivation, with effects that remained stable into young adulthood.
• Neuroprotection: A clinical study on ischemic stroke reported that Semax exposure was associated with improved restoration of neurological function, as measured by EEG mapping.
• Cardiovascular Research Value: In experimental myocardial infarction models, Semax showed potential to limit left-ventricular remodeling and cardiomyocyte hypertrophy.

How Semax Peptide Works

Semax's proposed mechanism centers on the inhibition of enzymes responsible for degrading enkephalins — naturally occurring neurotransmitters deeply involved in nociception and the stress response. By preserving enkephalin levels, the peptide may cascade into broader modulation of interconnected systems, including dopaminergic and serotonergic signaling, through altered neurotransmitter release, receptor activity, and signal transduction pathways. Independent research has additionally linked Semax to elevated dopamine secretion, increased BDNF expression, and changes in gene transcription governing immune cell mobility, chemokines, and immunoglobulins tied to vascular function. This multifaceted profile makes Semax a compelling subject for ongoing neurological and immunological research.

Usage Information

• Standard Dosage: 200–600 mcg daily
• Cycle Length: 10 to 20 days
• Maintenance: 2–3x/week for ongoing cognitive support

Product Specifications

Product Name	Semax Peptide
Active Ingredient	Semax – synthetic ACTH(4-7)Pro-Gly-Pro analog (Met-Glu-His-Phe-Pro-Gly-Pro)
Strength	See product listing for available research concentrations
Form	Lyophilized peptide (research use only)
Brand	Premium research peptide collection
Molecular Formula	C39H54N10O10S
Molecular Weight	854.99 g/mol
Also Known As	ACTH(4-7)PGP, HY-P1146

Quality & Manufacturing

Each batch of Semax Peptide is synthesized under controlled laboratory conditions and subjected to rigorous analytical verification to confirm identity, purity, and structural integrity. Standardized production protocols ensure consistent peptide content and molecular characteristics from batch to batch, so researchers can rely on reproducible results across experiments. The compound's acetylated structure and PGP C-terminal extension are preserved through careful synthesis and lyophilization, maintaining the stability advantages that distinguish Semax from unmodified endogenous peptide fragments.

Safety Information & Handling Considerations

• Research-Only Status: Semax Peptide is sold exclusively for scientific and laboratory research. 
• Limited Clinical Data: While preclinical findings are promising, large-scale clinical evidence remains limited; all experimental use should account for the investigational nature of this compound.
• Proper Handling: Use appropriate personal protective equipment and follow institutional laboratory safety procedures when handling, reconstituting, or disposing of the peptide.
• Storage Sensitivity: As with all peptides, improper storage or repeated freeze-thaw cycles may compromise stability — adhere to recommended storage guidelines.

Why Choose Our Semax Peptide?

Our Semax Peptide stands out through a commitment to analytical transparency and batch-to-batch consistency. Each lot undergoes independent quality verification before release, giving research teams documented confidence in what they receive. Combined with careful lyophilization, protective packaging, and responsive customer support, our peptide collection has earned the trust of laboratories seeking dependable compounds for neuroscience, immunology, and cardiovascular research programs.